Clinical Trial Update: Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial assessing MLS-101 for uncontrolled hypertension with renal involvement completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension
• Renal Hypertension

Drugs mentioned

• MLS-101

Snippet

Sponsor: Mineralys Therapeutics Inc. | Conditions: Hypertension, Renal | Phase 2 | Status: COMPLETED | Results posted: 2024-01-05